Advertisement
Advertisement
CRISPR Therapeutics AG (CRSP)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Advertisement
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 65.15 |
| Open | 66.57 |
| Bid | 66.50 x 900 |
| Ask | 66.84 x 900 |
| Day's Range | 61.06 - 67.16 |
| 52 Week Range | 42.51 - 169.76 |
| Volume | |
| Avg. Volume | 1,712,493 |
| Market Cap | 5.124B |
| Beta (5Y Monthly) | 2.01 |
| PE Ratio (TTM) | 12.72 |
| EPS (TTM) | 5.26 |
| Earnings Date | Apr 25, 2022 - Apr 29, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 121.86 |
- Barrons.com
Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead
Crispr Therapeutics Chief Executive Sam Kulkarni says the next two years of clinical trials and data readouts will give investors, and patients, plenty to cheer about.
- Yahoo Finance Video
Stocks cling to gains into the close, ARKK components surge, travel stocks in the red
Yahoo Finance's Jared Blikre checks out the market and sector action heading into today's close, software stocks, ARK ETF components, and the travel industry ahead of the close.
- Zacks
CRISPR Therapeutics AG (CRSP) Moves 8.3% Higher: Will This Strength Last?
CRISPR Therapeutics AG (CRSP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2022 Yahoo. All rights reserved.
